The HIV Glasgow congress, the 12th International Congress on Drug Therapy in HIV infection, took place in Glasgow, UK, 2nd-6th November 2014.

Conference highlights

Drug-resistant TB

One third of TB cases in Eastern European HIV clinic survey multi-drug resistant.

Generic drugs

Generic antiretrovirals could save NHS £1.25 billion over 5 years, study finds.

Summary bulletin

Catch up with our summary bulletin of news from the conference.

HIV treatment cascade

Australia performs best in HIV treatment cascade – 62% with undetectable viral load.

HIV therapy

Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?


Efavirenz compromises hormonal contraceptive implant.

aidsmap news from HIV Glasgow 2014

← First1Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference and view the programme on the official HIV Glasgow website.

Visit the HIV Glasgow website >

NAM's conference news reporting services have been made possible thanks to support from Merck & Co., Inc., Bristol-Myers Squibb and the Organising Committee of HIV Drug Therapy Glasgow.​

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.